Literature DB >> 26191287

Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.

Jiehua Li1, Haitian Zhang1, Yunfei Lu1, Zhibai Chen1, Ka Su1.   

Abstract

Approximately 15% of gastrointestinal stromal tumors (GIST) do not express KIT mutations and of these about 5 to 7% harbor mutations in PDGFRA. DOG1 was specifically expressed in GISTs. These cases require special attention for PDGFRA and DOG1 mutational status. Hundred cases of GIST were diagnosed between August 2007 and October 2012 at the First Affiliated Hospital of Guangxi Medical University. DNA from tumor tissues and normal adjacent tissues was isolated and amplified for the 22 exons of PDGFRA and 26 exons of DOG1. Each PCR product was sequenced. Amino acid sequences were inferred from DNA and aligned to GenBank reference sequences to determine the position and type of mutations. Overall, 16.0% of the samples had a mutation in PDGFRA, and GISTs with mutations in the DOG1 gene were not found. Of the mutations detected, they were in PDGFRA exon 18 (8 cases, 8%), PDGFRA exon 12 (5 cases, 5%), PDGFRA exon 14 (1 cases, 1.0%), PDGFRA exon 11 (1 cases, 1.0%), and PDGFRA exon 8 (1 cases, 1.0%). Of these, Y392S, L521P and T632K mutant occurred in PDGFRA exon 8, exon 11 and exon 14, respectively. The mutation of PDGFRA has been considered as another causative genetic event as PDGFRA mutations were found in most GISTs lacking a KIT mutation. PDGFRA mutations occurred preferentially in exon 18 and exon 12. Mutations occurring in PDGFRA exon 8 (Y392S), exon 11 (L521P) and exon 14 (T632K) also were first identified. The over-expression of DOG1 was not related to DOG1 gene mutation.

Entities:  

Keywords:  DOG1; Gastrointestinal stromal tumor; mutation; platelet-derived growth factor alpha

Mesh:

Substances:

Year:  2015        PMID: 26191287      PMCID: PMC4503158     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Authors:  Hidetaka Yamamoto; Aya Kojima; Shigenori Nagata; Yasuhiko Tomita; Satsuki Takahashi; Yoshinao Oda
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

2.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

3.  Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).

Authors:  Shigeharu Miwa; Takahiko Nakajima; Yoshihiro Murai; Yasuo Takano; Toshiro Sugiyama
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

4.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.

Authors:  Katherine A Janeway; Su Young Kim; Maya Lodish; Vânia Nosé; Pierre Rustin; José Gaal; Patricia L M Dahia; Bernadette Liegl; Evan R Ball; Margarita Raygada; Angela H Lai; Lorna Kelly; Jason L Hornick; Maureen O'Sullivan; Ronald R de Krijger; Winand N M Dinjens; George D Demetri; Cristina R Antonescu; Jonathan A Fletcher; Lee Helman; Constantine A Stratakis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 5.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

6.  Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.

Authors:  Ann W Gramza; Christopher L Corless; Michael C Heinrich
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors.

Authors:  Muna Sabah; Robert Cummins; Mary Leader; Elaine Kay
Journal:  Mod Pathol       Date:  2004-11       Impact factor: 7.842

Review 8.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

Review 9.  Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.

Authors:  J Lasota; M Miettinen
Journal:  Histopathology       Date:  2008-02-28       Impact factor: 5.087

10.  Gastrointestinal stromal tumors: a review of case reports, diagnosis, treatment, and future directions.

Authors:  Christopher B Tan; Wanqing Zhi; Ghulamullah Shahzad; Paul Mustacchia
Journal:  ISRN Gastroenterol       Date:  2012-04-12
View more
  3 in total

Review 1.  Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Authors:  Berna C Özdemir; Gian-Paolo Dotto
Journal:  Trends Cancer       Date:  2017-03-06

2.  Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).

Authors:  Jiang Du; Si Wang; Rui Wang; Si-Yao Wang; Qiang Han; Hong-Tao Xu; Peng Yang; Yang Liu
Journal:  Pathol Oncol Res       Date:  2019-11-22       Impact factor: 3.201

3.  Molecular and Immunohistochemical Study of Platelet Derived Growth Factor Receptor Alpha in KIT Negative Gastrointestinal Stromal Tumors; the First Report from Iran.

Authors:  Bita Geramizadeh; Zahra Jowkar; Seyed-Javad Mousavi
Journal:  Middle East J Dig Dis       Date:  2016-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.